Exact Sciences Highlights the Impact of Precision Oncology Portfolio on Breast Cancer Treatment with 10 New Data Presentations at SABCS® 2022

/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that new data presentations...

Related Keywords

Canada ,San Antonio ,Texas ,United States ,Quebec ,United Kingdom ,Josepha Sparano ,Gisela Pedroza ,Rick Baehner ,Federico Maiardi ,Megan Jones ,Sciences Corp ,Sciences On Facebook ,National Cancer Institute ,Sciences On Twitter Exactsciences ,Cancer Research Group ,Nasdaq ,Exchange Commission ,Genomic Health Inc ,Sciences Precision Oncology Portfolio ,Cancer Research Network ,Sciences Corporation ,Exact Science ,Exact Sciences ,Precision Oncology ,Antonio Breast Cancer ,Recurrence Score ,Research Group ,Trial Assigning Individualized Options ,Tisch Cancer Center ,Mount Sinai Health ,Positive Node ,Endocrine Responsive Breast Cancer ,Research Network ,New England Journal ,Exact Sciences Precision Oncology Portfolio ,Scottish Conservation ,Breast Recurrence ,Oncomap Extra ,Exact Science Precision Oncology ,Science Precision Oncology ,Genomic Health ,Risk Factors ,Annual Report ,Quarterly Reports ,Exact Sciences Corp ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Computer Amp Electronics ,Medical Equipment ,Otc ,Mallcap ,Clinical Trials Amp Medical Discoveries ,